Topic: MS

Treatment discontinuation in MS: the DOT-MS trial

May 5, 2025  

CLINICAL CASES IN MS: A 24 Y.O. WOMAN WITH PARESTHESIAE AND NON-ENHANCING LESIONS

April 25, 2025  

AAN 2025 – report on fluid biomarkers in MS

April 22, 2025  

Ofatumumab – new data on efficacy and safety

April 14, 2025  

AAN DAILY HIGHLIGHTS – WEDNESDAY, APRIL 9, 2025

April 9, 2025  

AAN DAILY HIGHLIGHTS – TUESDAY, APRIL 8, 2025

April 8, 2025  

AAN DAILY HIGHLIGHTS – MONDAY, APRIL 7, 2025

April 7, 2025  

ACTRIMS Forum 2025 highlights – Update on ocrelizumab

March 24, 2025  

ACTRIMS Forum 2025: Update on biomarkers

March 17, 2025  

CLINICAL CASES IN MS: A PATIENT WITH WORSENING FATIGUE AND NEW MOBILITY PROBLEMS

March 13, 2025